AIM IMMUNOTECH INC. Total Long-Term Debt
AIM IMMUNOTECH INC. (AIM) had Total Long-Term Debt of $3.62 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-08-07
- 2026-06-30: Long-term Debt $3.62M.
- 2026-03-31: Long-term Debt $4.21M.
- 2025-12-31: Long-term Debt $4.48M.
- 2025-06-30: Long-term Debt $2.72M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $3.62M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.21M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.48M 10-Q · filed 2026-08-07 |
| 2025-06-30 | $2.72M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.39M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.81M 10-K · filed 2026-03-27 |
| 2024-09-30 | $3.30M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.30M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.33M 10-Q · filed 2024-05-15 |
| 2021-03-31 | $2.05M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $2.11M 10-K · filed 2021-03-31 |
| 2020-09-30 | $2.16M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.21M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.27M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.32M 10-K · filed 2020-03-30 |
| 2019-09-30 | $2.37M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.42M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.47M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.52M 10-K · filed 2019-04-01 |
| 2018-09-30 | $2.57M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.61M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.66M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |